Psychae Institute

Psychae Institute Psychae Institute works to develop psychedelics therapies as registered medical treatments

Our Mission
Psychae Institute is dedicated to developing novel psychedelic therapies as registered medical treatments for mental disorders and other diseases, as well as supporting psychological wellbeing. We are achieving this using world-class biopharmaceutical research and development approaches within our global partner network. Our Vision
We envision a world where rigorously tested scientific

ally-supported psychedelic medicines are an additional treatment option within mainstream health systems for people experiencing mental health disorders and other health conditions. Our Work
- Undertaking clinical and pre-clinical research investigating potential medical applications of psychedelic compounds

- Developing innovative psychedelic treatment models and technologies that can enhance therapeutic outcomes

- Working with regulators and governments to advance research in the field to enable future evidence-informed safe patient access to psychedelic medicines

- Learning from and acknowledging traditional knowledge/users of psychedelic substances

- Recognising and giving back to the communities and groups whose healing traditions inform our treatments

- Working with people with ‘lived experience’ of their health condition, and soliciting their valued input into our research

Our Values:
- Integrity (having taken North Star Ethics Pledge)
- Respect
- Sustainability
- Collaboration
- Innovation
- Passion & Compassion
- Research Excellence

https://www.linkedin.com/events/advancingpsychedelic-assistedth7211623423460933632/about/Learn about the pioneering adva...
03/07/2024

https://www.linkedin.com/events/advancingpsychedelic-assistedth7211623423460933632/about/
Learn about the pioneering advances in Psychedelic-Assisted Therapy from Switzerland, where legal access pathways have been in place since 2014!

Join us for a webinar with Dr. Helena Aicher, clinician and researcher at the University of Zurich, who will provide insights into the use of L*D, M**A and psilocybin in Swiss clinical and research settings.

Address

Pyalong, VIC

Alerts

Be the first to know and let us send you an email when Psychae Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Psychae Institute:

Share